针对COPD中调节细胞死亡途径:机制和治疗策略
Hao Fu1, Qian Huang1, Jungang Xie1
1Department of Respiratory and Critical Care Medicine, National Clinical Research Center of Respiratory Disease, Key Laboratory of Pulmonary Diseases of Health Ministry, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Cells
|December 10, 2025
概括
调节细胞死亡 (RCD) 途径越来越多地与慢性阻塞性肺病 (COPD) 的发展有关. 针对这些途径为COPD患者提供了潜在的新疗法.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 分子机制的分子机制
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个主要的全球健康问题,其特点是持续的空气流量限制和炎症.
- 精确的细胞机制驱动COPD的发病,特别是涉及细胞死亡,尚未完全理解.
- 调控细胞死亡 (RCD) 涵盖了除了细胞亡之外的各种途径,包括死细胞亡,热细胞亡,铁细胞亡等.
研究的目的:
- 审查通过各种RCD途径促进COPD发病和进展的分子机制.
- 探索针对COPD治疗的RCD途径的治疗潜力.
- 提高对COPD病理生理学的理解,并确定新的治疗策略.
主要方法:
- 文献综述综合了关于COPD中RCD途径的当前研究.
- 对将特定的RCD类型与COPD病原体联系起来的分子机制的分析.
- 对COPD中RCD向剂的临床前和临床证据的评估.
主要成果:
- 越来越多的证据表明,RCD途径在COPD的发展和进展中发挥着重要作用.
- 特定的RCD途径,如死细胞灭绝,烧细胞灭绝和铁细胞灭绝,都与呼吸道炎症和重塑有关.
- 针对RCD途径的药物在临床前COPD模型中显示出潜在的治疗益处.
结论:
- 调节的细胞死亡途径是COPD的关键调解者.
- 准RCD途径是新型COPD治疗方法的一个有希望的途径.
- 对RCD机制的进一步研究可以解锁COPD的创新治疗策略.
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
700
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
700
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K